Rick Pazdur, formerly the FDA’s top oncology official, said the FDA is at a critical juncture that could determine the direction of the world’s top regulator of medicines. Pazdur spoke during a STAT panel discussion during the annual meeting of the American Society of Clinical Oncology.
The post Former FDA Officials: There’s Opportunity to Rebuild the Agency — But Not the Way It Was appeared first on MedCity News.
